Neutralising VEGF/VEGFR signalling in tumours is able to potentiate the efficacy and efficiency of cancer immunotherapy by elevating the expression of adhesion molecules and chemokines necessary for leucocyte capture [22,56,58]. Here, VEGFA is linked to cancer.